Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients

NCT06604260 is registered in ClinicalTrials.gov with Dalia Lartey as lead sponsor.

NCT NCT06604260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06604260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients
Lead sponsor
Dalia Lartey
Phase
Phase 2
Overall status
Recruiting
Start date
August 31, 2023
Completion date
December 31, 2024
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease (cd), ibd (inflammatory bowel disease), ulcerative colitis (uc)